MoneyWorks4Me

Zydus Lifesciences informs about press release

04 May 2024 Evaluate

Zydus Lifesciences has informed that it enclosed a copy of press release dated May 4, 2024 titled ‘Sentynl Therapeutics announces global acquisition of Zokinvy® (Lonafarnib) for treatment of Hutchinson-Gilford Progeria Syndrome from Eiger Biopharmaceuticals’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1741.65
Dr. Reddys Labs. 1239.00
Cipla 1325.75
Lupin 1944.90
Zydus Lifesciences 1118.10
View more..